The average Prime Therapeutics VP of Investor Relations earns an estimated $124,875 annually. Prime Therapeutics' VP of Investor Relations compensation is $6,533 less than the US average for a VP of Investor Relations.
The Communications Department at Prime Therapeutics earns $6,617 more on average than the Customer Support Department.
Last updated a year ago.
VPs of Investor Relations earn $42,002 more than Editors.
The Communications Department averages $6,617 more than the Customer Support Department, and $3,497 less than the IT Department
The majority of VPs of Investor Relations at Prime Therapeutics believe they're compensated fairly. 100% of VPs of Investor Relations at Prime Therapeutics say they receive annual bonuses, and the vast majority (77%) are satisfied with their benefits. See more compensation ratings at Prime Therapeutics